Results from a phase 1b/2 study of RX-0201, a novel AKT-1 antisense, combined with everolimus to treat metastatic clear cell renal carcinoma.

被引:2
作者
Agarwal, Neeraj
Tagawa, Scott T.
Chatta, Gurkamal S.
Pal, Sumanta K.
Goel, Sanjay
Mazhari, Reza
Heaton, Callie
Benaim, Ely
机构
[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[2] Weill Cornell Med, New York, NY USA
[3] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[4] City Hope Natl Med Ctr, Duarte, CA USA
[5] Montefiore Einstein Ctr Canc Care, Bronx, NY USA
[6] Rexahn Pharmaceut Inc, Rockville, MD USA
关键词
D O I
10.1200/JCO.2016.34.15_suppl.2559
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2559
引用
收藏
页数:2
相关论文
empty
未找到相关数据